Navigation

magnesium citrate

 

Classes: Laxatives, Saline

Dosing and uses of Magnesium citrate

 

Adult dosage forms and strengths

liquid

  • 290mg/5mL

tablet

  • 100mg (elemental)

 

Nutritional Supplementation

19-30 years: Men, 400 mg/day; women, 310 mg/day; pregnant women (≤50 years), 350 mg/day; breastfeeding women (≤50 years), 310 mg/day

>30 years: Men, 420 mg/day; women, 320 mg/day; pregnant women (≤50 years), 360 mg/day; breastfeeding women (≤50 years), 320 mg/day

 

Constipation/Bowel Evacuation

195-300 mL PO in single daily dose or in divided doses with full glass of water

Alternative: 2-4 tablets PO at bedtime

 

Acid Indigestion

1 tablet twice daily or as directed by healthcare provider

 

Pediatric dosage forms and strengths

liquid

  • 290mg/5mL

tablet

  • 100mg (elemental)

 

Constipation/Bowel Evacuation

<2 years: Safety and efficacy not established

2-6 years: 60-90 mL PO once or divided doses; not to exceed 90 mL/24hr

6-12 years: 90-210 mL in single dose or in divided doses with full glass of water

>12 years: 195-300 mL PO in single daily dose or in divided doses with full glass of water; alternatively, may administer 2-4 tablets PO at bedtime

 

Magnesium citrate adverse (side) effects

Frequency not defined

Abdominal cramping

Diarrhea

Electrolyte imbalance

Hypermagnesemia

Gas formatioin

Nausea/vomiting

 

Warnings

Contraindications

Low sodium diet

 

Cautions

Use caution in renal insufficiency or magnesium-restricted diet

For occasional use only in treatment of constipation

Use with caution in patients with myasthenia gravis or other neuromuscular disease

Should be refrigerated to maintain potency and palatability

Avoid use in renal failure, existing electrolyte imbalance, appendicitis or acute surgical abdomen, myocardial damage or heart block, fecal impaction or rectal fissures, intestinal obstruction or perforation, dehydration

 

Pregnancy and lactation

Pregnancy category: A

Lactation: Use in nursing mothers appears to be safe

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Magnesium citrate

Mechanism of action

Increases peristaltic activity of the colon; promotes bowel evacuation by causing osmotic retention of fluid

 

Absorption

15-30% absorbed

Onset: 0.5-6 hr or less

 

Elimination

Excretion: Urine (mainly)